Avidity Biosciences (RNA) Income Statement: Revenue & Earnings

Avidity Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Avidity Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	10.90	9.56	9.22	9.33	6.79
Cost of Revenue	0.00	190.97	150.40	101.18	37.60
Gross Profit	10.90	9.56	-141.18	9.33	-30.82
Operating Expenses
Research & Development	303.59	190.97	150.40	101.18	37.60
Selling, General & Administrative	86.24	54.19	37.73	26.20	13.46
Operating Expenses	389.83	245.16	37.73	127.38	13.46
Operating Income	-378.94	-235.60	-178.91	-118.05	-44.28
Other Income/Expense
Interest Income	56.88	23.97	4.98	0.10	0.21
Interest Expense	0.00	0.00	0.00	0.00	-0.21
Other Income/Expense	56.63	-0.59	-0.06	-0.06	-0.08
Income
Income Before Tax	-322.30	-212.22	-174.00	-118.01	-44.36
Income Tax Expense	0.00	-5.88	-11.82	-7.87	-3.00
Net Income	-322.30	-212.22	-174.00	-118.01	-44.36
Net Income - Continuous Operations	-322.30	-212.22	-174.00	-118.01	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-376.16	-233.50	-177.53	-117.41	-43.90
EBIT	-330.47	-235.60	-178.91	-118.05	-44.28
Depreciation & Amortization	2.78	2.10	1.39	0.64	0.37
Earnings Per Share
Basic EPS	-3.00	-3.00	-3.00	-6.00	-2.00
Diluted EPS	-3.00	-3.00	-3.00	-6.00	-2.00
Basic Shares Outstanding	111.58	73.01	52.16	20.71	21.66
Diluted Shares Outstanding	111.58	73.01	52.16	20.71	21.66